PPM ACCESS
Access to the PPM Journal and newsletters is FREE for clinicians.
Signup for PPM

All Multiple Sclerosis Articles

Pain and pain-related illness, as well as beliefs about pain, had a limiting effect on the ability of individuals with multiple sclerosis (MS) to engage in activities, based on data from 161 adults with MS who reported at least mild pain.
This article discusses treatment of neuropathic pain in multiple sclerosis and explains how patients demonstrated improvement using the oral synthetic cannabinoid nabilone.
More than 40% of multiple sclerosis (MS) patients experience at least one type of pain. Learn more about diagnosing and treating MS patients with pain.
close X
SHOW MAIN MENU
SHOW SUB MENU